ERYtech Pharma is a biopharmaceutical company, develops enzyme-based medicinal products for the oncology, hematology and immunology sectors.
ERYtech Pharma specializes in the encapsulation of therapeutic molecules and enzymes in red blood cells. It has achieved a major breakthrough in the fields of cancer and enzyme therapy by significantly increasing the therapeutic index of the encapsulated molecule or enzyme.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 22, 2006 | Series Unknown | €12M | 1 | — | — | Detail |
Nov 3, 2005 | Series A | €750K | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Amorçage Rhône Alpes | — | Series Unknown |